Анестезия и педиатрия - Джордж А.Г.
ISBN 5-225-03821-2
Скачать (прямая ссылка):
233. Donati F, Be van DR: Potentiation of succinylcholine phase l| block with isoflurane. Anesthesiology 58:552, 1983
234. Lindgrcn L, Saarnivaara L: Increase in intragastric pressure during suxamethonium induced muscle fuseicofnt ions in children: inhibition by alfentanil. Br J Anacsth 60:176,
1988
235. Ryan JF. Kagen U. Hyman AL: Myoglobinemia after a single dose of succinylcholinc. N Engl J Med 285:824, 1971
236. Lerman J. Robinson S, Willis MM et al: Succinylcholinc-induced heart rate changes in children during isoflurane and halothanc. Anesthesiology 59:A443, 1983
237. GronenGA.Theye RL: Pathophysiology of hyperkalemia induced by succinylcholinc. Anesthesiology 43:89. 1975
238. Schaner PJ. Brown RL. Kirscy TD et al: Succinylcholine induced hyperkalemia in burned patients. Anesth Analg 48:764. I%9
239. Dclphin E, Jackson D. Rothstein P: Use of succinylcho-line during elective pediatric anesthesia should be reevaluated. Anesth Analg 66:1190, 1987
240. Kepes ER, Martinez LR. Andrews 1C et al: Anesthctic
frobtems in hereditary muscular abnormalities. NY State Med 72:1051, 1972
241. Larach MG, Rosenberg H, Gronctt GA. Allen GC: Hy-perkalemic cardiac arrest during anesthesia in infants and children with occult myopathies. Clin Pediatr 36:9. 1997
242. Dan ton JV. Newfield P. Sreter F, Ryan JF: Implications of masscter spasm after succinylcholinc. Anesthesiology 49:298, 1978
243. Flewellen EH, Nelson ТЕ: Halothane-succinylcholine induced massetcr spasm: indicative of malignant hyperthermia susceptibility? Anesth Analg 63:393. 1984
244. Van Der Spck AFL, Fang WB, Ashton-Miller JA et al: The effects of succinylcholine on mouth opening. Anesthesiology 67:459. 1987
245. Carroll JB: Increased incidence of masscter spasm in children with strabismus anesthetized with haloihane-succi-nylcholine. Anesthesiology 67:559, 1987
246. Rosenberg H. Fletcher JE: Masseter muscle rigidity and malignant hyperthermia susceptibility. Anesth Analg 65:161, 1986
247. Meakin C, Walker RW. Dearlove OR: Myotonic and neuromuscular blocking effects of increased doses of suxamethonium in infants and children. Br J Anaesth 65:816, 1990
248. O’Sullivan EP. Childs D, Bush GH: Perioperative dreaming in paediatric patients who receive suxamethonium. Anaesthesia 43:104. 1988
249. Cote CJ. Petkau AJ: Thiopental requirements may be increased in children reancsthetized at least one year after recovery from extensive thermal iiyjury. Anesth Analg 64:1156. 1985
250. Brett CM. Fisher DM: Thiopental dose-response relations in unpremedicated infants, children, and adults. Anesth Analg 66:1024, 1987
251. Sorbo S. Hudson RJ, Loomis JC. The pharmacokinetics
64 Анестезия в педиатрии
of thiopental in pediatric surgical petients. Anesthesiology 61:666. 1984
252. Cote DJ. Goitdsouzian NG, Liu LMP et al: The dose response of intravenous thiopental for the induction of general anesthesia in unpremedicated children. Anesthesiology 55:703, 1981
253. Wodey E, Chonow L, Beneux X, et al: Haemodynamic effects of propofol vs thiopental in infants: an echocardi-ographic study. Br J Anaesth 82:516. 1999
254. Bhutada A, Sahni R, Rastogi S, Wung JT: Randomised controlled trial of thiopental for intubation in neonates. Arch Dis Child Fetal Neonatal Ed 82:F34, 2000
255. Carmichael EB: The median lethal dose (LD^) of pen-tothal sodium for both youog and old guinea pigs and rats. Anesthesiology 8:589, 1947
256. Koska Y, Takahashi E, Mark LC: Intravenous thiobarbit-urate anesthesia for cesarean section. Anesthesiology 31:489, 1959
257. Domek NS, Barlow CF, Roth LJ: Ал octogenetic study of phenobarbital C-14 in cat brain. J Pharmacol Exp Ther 130:285, I960
258. Brown AK, Zwelzin WW, Burnett H H: Studies on the neonatal development of the glucuronide conjugation system. J Clin Invest 37:332, 1958
259. Kaiser SC, Forties E, Kunig R: Relation of brain sensitivity of hepatic metabolism of hexobaibitone to dose-response relations in infant and young rats. J Pharmacol 21:109,
1969
260. Onishi S, Ohki Y, Nishimuru Y et al: Distribution of pentobarbital in serum, brain, and other organs from pediatric patients. Dev Pharmacol Ther 7:153, 1984
261. Gal P. Toback J, Erkan NV, Boer HR: The influence of asphyxia on phenobarbital dosing requirments in neonates. Dev Pharmacol Ther 7:145, 1984
262. Kadar D, Tang BK, Conn AW: The fate of pentobarbitone in children in hypothermia and at normal body temperature. Can Anaesth Soc J 29:16, 1982
263. Kanto J. Gepts E: Pharmacokinetic implications for the clinical use of propofol. Clin Pharmacokinet 17:308, 1989
264. Vandermeersch E, Van JH, Byttebier G, Van AH: Pharmacokinetics of propofol during continuous infusion tor pediatric anesthesia. Acta Anaesthiol Be|g 40:161, 1989
265. Kulkami P, Brown KA: Ventilatory parameters in children during propofol anaesthesia: a comperison with halothane. Can J Anaesth 43:653, 1996
266. Spens HJ. Drummond GB, Wraith PK: Changes in chest wall comparatment volumes on induction of anaesthesia with eltanolone, propofol and thiopentone. Br J Anaesth 76:369, 1996
